Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma.
暂无分享，去创建一个
D. Schadendorf | R. Dummer | A. Testori | C. Punt | C. Robert | P. Patel | S. Suciu | U. Keilholz | M. Santinami | F. Sales | A. Spatz | W. Kruit | J. Marsden | A. Eggermont | G. de Schaetzen | Gaetan de Schaetzen